Lv41
560 积分 2023-04-27 加入
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
3小时前
已完结
Synthetic Approaches to the New Drugs Approved During 2024
21天前
已完结
Can PROTACs truly become oral drugs?
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
6个月前
已完结
Global landscape of PROTAC: Perspectives from patents, drug pipelines, clinical trials, and licensing transactions
10个月前
已完结
Discovery of KIN-8741, a Highly Selective Type IIb c-Met Kinase Inhibitor with Broad Mutation Coverage and Quality Drug-Like Properties for the Treatment of Cancer
11个月前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
11个月前
已完结
皖公网安备34019202002308
